Incidence of Vaccine-Preventable Childhood Diseases in the European Union and in the European Free Trade Association Countries
Introduction: Despite the widespread availability of vaccines, the incidence of vaccine-preventable childhood diseases (VPCD) started to grow in recent years. The aim of the study was to compare the annual incidence of selected VPCDs in the EU (European Union) and EFTA (European Free Trade Associati...
Uložené v:
| Vydané v: | Vaccines (Basel) Ročník 9; číslo 7; s. 796 |
|---|---|
| Hlavní autori: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Basel
MDPI AG
17.07.2021
MDPI |
| Predmet: | |
| ISSN: | 2076-393X, 2076-393X |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Introduction: Despite the widespread availability of vaccines, the incidence of vaccine-preventable childhood diseases (VPCD) started to grow in recent years. The aim of the study was to compare the annual incidence of selected VPCDs in the EU (European Union) and EFTA (European Free Trade Association) countries in the period of the last 5 years (2014–2019 or other intervals, depending on data availability), and the country-specific vaccine schedules. Methods: VPCD incidence rates in Europe were based on “The Surveillance Atlas of Infectious Diseases” by the ECDC (European Centre for Disease Prevention and Control); vaccination schedules were based on ECDC reports. Results: The obligation to vaccinate was not universal, and it generally only applied to two preparations: the MMR (measles, mumps, rubella) vaccine and the one against polio. During the study, the situation associated with mumps did not change or improve in individual countries; the median incidence amounted to 30 cases. The median incidence associated with rubella amounted to 1 case, but in a few countries, it grew very rapidly, i.e., in Germany, Italy, and Romania; in Poland, the incidence was clearly decreasing, from 5923 to 1532 cases. The most dynamic situation concerned measles. The total median was 2.4 cases per 100,000 population; the only one country with falling incidence was Germany. The diseases associated with Streptococcus pneumoniae and Neisseria meningitidis remained at a stable level in all analyzed countries. Conclusion: Vaccine schedules differ among the countries, so does the epidemiological situation of selected diseases. Morbidity on measles was the most disturbing phenomenon: the incidence rate increased in almost 40% of all countries, regardless of the obligation to vaccinate. The increasing incidence of VPCD may be due to anti-vaccine movements, the activity of which is often caused by mistrust and spreading misinformation. In order to better prevent the increase in morbidity, standardization of vaccine schedules and documentation should be considered in the EU countries. |
|---|---|
| AbstractList | Introduction: Despite the widespread availability of vaccines, the incidence of vaccine-preventable childhood diseases (VPCD) started to grow in recent years. The aim of the study was to compare the annual incidence of selected VPCDs in the EU (European Union) and EFTA (European Free Trade Association) countries in the period of the last 5 years (2014–2019 or other intervals, depending on data availability), and the country-specific vaccine schedules. Methods: VPCD incidence rates in Europe were based on “The Surveillance Atlas of Infectious Diseases” by the ECDC (European Centre for Disease Prevention and Control); vaccination schedules were based on ECDC reports. Results: The obligation to vaccinate was not universal, and it generally only applied to two preparations: the MMR (measles, mumps, rubella) vaccine and the one against polio. During the study, the situation associated with mumps did not change or improve in individual countries; the median incidence amounted to 30 cases. The median incidence associated with rubella amounted to 1 case, but in a few countries, it grew very rapidly, i.e., in Germany, Italy, and Romania; in Poland, the incidence was clearly decreasing, from 5923 to 1532 cases. The most dynamic situation concerned measles. The total median was 2.4 cases per 100,000 population; the only one country with falling incidence was Germany. The diseases associated with Streptococcus pneumoniae and Neisseria meningitidis remained at a stable level in all analyzed countries. Conclusion: Vaccine schedules differ among the countries, so does the epidemiological situation of selected diseases. Morbidity on measles was the most disturbing phenomenon: the incidence rate increased in almost 40% of all countries, regardless of the obligation to vaccinate. The increasing incidence of VPCD may be due to anti-vaccine movements, the activity of which is often caused by mistrust and spreading misinformation. In order to better prevent the increase in morbidity, standardization of vaccine schedules and documentation should be considered in the EU countries. Despite the widespread availability of vaccines, the incidence of vaccine-preventable childhood diseases (VPCD) started to grow in recent years. The aim of the study was to compare the annual incidence of selected VPCDs in the EU (European Union) and EFTA (European Free Trade Association) countries in the period of the last 5 years (2014-2019 or other intervals, depending on data availability), and the country-specific vaccine schedules.INTRODUCTIONDespite the widespread availability of vaccines, the incidence of vaccine-preventable childhood diseases (VPCD) started to grow in recent years. The aim of the study was to compare the annual incidence of selected VPCDs in the EU (European Union) and EFTA (European Free Trade Association) countries in the period of the last 5 years (2014-2019 or other intervals, depending on data availability), and the country-specific vaccine schedules.VPCD incidence rates in Europe were based on "The Surveillance Atlas of Infectious Diseases" by the ECDC (European Centre for Disease Prevention and Control); vaccination schedules were based on ECDC reports.METHODSVPCD incidence rates in Europe were based on "The Surveillance Atlas of Infectious Diseases" by the ECDC (European Centre for Disease Prevention and Control); vaccination schedules were based on ECDC reports.The obligation to vaccinate was not universal, and it generally only applied to two preparations: the MMR (measles, mumps, rubella) vaccine and the one against polio. During the study, the situation associated with mumps did not change or improve in individual countries; the median incidence amounted to 30 cases. The median incidence associated with rubella amounted to 1 case, but in a few countries, it grew very rapidly, i.e., in Germany, Italy, and Romania; in Poland, the incidence was clearly decreasing, from 5923 to 1532 cases. The most dynamic situation concerned measles. The total median was 2.4 cases per 100,000 population; the only one country with falling incidence was Germany. The diseases associated with Streptococcus pneumoniae and Neisseria meningitidis remained at a stable level in all analyzed countries.RESULTSThe obligation to vaccinate was not universal, and it generally only applied to two preparations: the MMR (measles, mumps, rubella) vaccine and the one against polio. During the study, the situation associated with mumps did not change or improve in individual countries; the median incidence amounted to 30 cases. The median incidence associated with rubella amounted to 1 case, but in a few countries, it grew very rapidly, i.e., in Germany, Italy, and Romania; in Poland, the incidence was clearly decreasing, from 5923 to 1532 cases. The most dynamic situation concerned measles. The total median was 2.4 cases per 100,000 population; the only one country with falling incidence was Germany. The diseases associated with Streptococcus pneumoniae and Neisseria meningitidis remained at a stable level in all analyzed countries.Vaccine schedules differ among the countries, so does the epidemiological situation of selected diseases. Morbidity on measles was the most disturbing phenomenon: the incidence rate increased in almost 40% of all countries, regardless of the obligation to vaccinate. The increasing incidence of VPCD may be due to anti-vaccine movements, the activity of which is often caused by mistrust and spreading misinformation. In order to better prevent the increase in morbidity, standardization of vaccine schedules and documentation should be considered in the EU countries.CONCLUSIONVaccine schedules differ among the countries, so does the epidemiological situation of selected diseases. Morbidity on measles was the most disturbing phenomenon: the incidence rate increased in almost 40% of all countries, regardless of the obligation to vaccinate. The increasing incidence of VPCD may be due to anti-vaccine movements, the activity of which is often caused by mistrust and spreading misinformation. In order to better prevent the increase in morbidity, standardization of vaccine schedules and documentation should be considered in the EU countries. |
| Author | Urbanowicz, Juri Plakhtyr, Daria Jachowicz, Estera Wójkowska-Mach, Jadwiga Gębicka, Magdalena Marchewka, Jakub Shynkarenko, Myroslav Mach, Maciej Czepiel, Jacek |
| AuthorAffiliation | 5 Department of Infectious and Tropical Diseases, Jagiellonian University Medical College, 30-688 Krakow, Poland; jacek.czepiel@uj.edu.pl 1 Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, Poland; estera.jachowicz@doctoral.uj.edu.pl 4 Student of Quantitative Methods in Economics SGH Warsaw School of Economics, 02-554 Warsaw, Poland; mach-maciej@wp.pl 3 Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, Poland; daria.plakhtyr@student.uj.edu.pl (D.P.); myroslav.shynkarenko@student.uj.edu.pl (M.S.); yuriy.urbanovych@student.uj.edu.pl (J.U.) 6 Department of Physiotherapy, University of Physical Education, 31-571 Kracow, Poland; jakub.marchewka@awf.krakow.pl 2 Department of Immunology, Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, Poland; magdalena.gebicka@doctoral.uj.edu.pl |
| AuthorAffiliation_xml | – name: 3 Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, Poland; daria.plakhtyr@student.uj.edu.pl (D.P.); myroslav.shynkarenko@student.uj.edu.pl (M.S.); yuriy.urbanovych@student.uj.edu.pl (J.U.) – name: 6 Department of Physiotherapy, University of Physical Education, 31-571 Kracow, Poland; jakub.marchewka@awf.krakow.pl – name: 5 Department of Infectious and Tropical Diseases, Jagiellonian University Medical College, 30-688 Krakow, Poland; jacek.czepiel@uj.edu.pl – name: 2 Department of Immunology, Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, Poland; magdalena.gebicka@doctoral.uj.edu.pl – name: 1 Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, Poland; estera.jachowicz@doctoral.uj.edu.pl – name: 4 Student of Quantitative Methods in Economics SGH Warsaw School of Economics, 02-554 Warsaw, Poland; mach-maciej@wp.pl |
| Author_xml | – sequence: 1 givenname: Estera surname: Jachowicz fullname: Jachowicz, Estera – sequence: 2 givenname: Magdalena surname: Gębicka fullname: Gębicka, Magdalena – sequence: 3 givenname: Daria surname: Plakhtyr fullname: Plakhtyr, Daria – sequence: 4 givenname: Myroslav surname: Shynkarenko fullname: Shynkarenko, Myroslav – sequence: 5 givenname: Juri surname: Urbanowicz fullname: Urbanowicz, Juri – sequence: 6 givenname: Maciej surname: Mach fullname: Mach, Maciej – sequence: 7 givenname: Jacek orcidid: 0000-0002-9997-8417 surname: Czepiel fullname: Czepiel, Jacek – sequence: 8 givenname: Jakub surname: Marchewka fullname: Marchewka, Jakub – sequence: 9 givenname: Jadwiga orcidid: 0000-0003-0756-1639 surname: Wójkowska-Mach fullname: Wójkowska-Mach, Jadwiga |
| BookMark | eNp1ks1rGzEQxUVJaFI3514FvfSyjb5391IITtIaAskhKb0JfczGMmvJlXYNvfRv7zoOpXGJLhIz7_0YnuYdOoopAkIfKPnMeUvOt8a5EKG0pCZ1q96gU0ZqVfGW_zj6532CzkpZkem0lDeqfotOuOCyYZSdot-L6IKH6ACnDn_fE6u7DFuIg7E94Pky9H6ZkseXoYApUHCIeFgCvhpz2oCJ-CGGFLGJ_r_OdQbA99l4wBelJBfMsJPO0xiHHKC8R8ed6QucPd8z9HB9dT__Vt3cfl3ML24qJ5QYKuC1kiBs29AOgFvGZWuN8h0TChrnlGEgjGRKMk47IhsnOmo6kFSQCWD5DC32XJ_MSm9yWJv8SycT9FMh5Udt8hBcD1ox6YnlyrWGCZDEusbVDbfCSyrtFOgMfdmzNqNdg3dTUNn0L6AvOzEs9WPa6oZTwqSaAJ-eATn9HKEMeh2Kg743EdJYNJOyFUwKzibpxwPpKo05TlHtVEJJwdROdb5XuZxKydD9HYYSvVsVfbAqk0MeOFwYnv5mmjj0r_r-ANa6xug |
| CitedBy_id | crossref_primary_10_3390_vaccines11030508 crossref_primary_10_3390_jcm11061698 |
| Cites_doi | 10.1371/journal.pone.0231329 10.1093/cid/ciz578 10.1093/clinids/4.5.940 10.3390/antibiotics10070758 10.1136/bmj.325.7361.430 10.3390/ijerph18030988 10.21101/cejph.a4408 10.2807/esm.10.09.00564-en 10.1186/s12879-020-05462-0 10.1016/S2589-7500(20)30227-2 10.1016/j.jinf.2021.05.031 10.1542/peds.2019-0620 10.1016/S0140-6736(07)61016-2 10.4103/0019-5545.82529 10.1080/21645515.2017.1412021 10.1136/archdischild-2013-305693 10.1016/j.vaccine.2017.07.051 10.1038/s41598-019-41983-8 10.1086/378092 10.15585/mmwr.mm6945a6 10.1016/S0140-6736(20)31558-0 10.1016/j.pop.2020.05.003 10.1080/21645515.2018.1532248 |
| ContentType | Journal Article |
| Copyright | 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 by the authors. 2021 |
| Copyright_xml | – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 by the authors. 2021 |
| DBID | AAYXX CITATION 3V. 7T7 7XB 8FD 8FE 8FH 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 GNUQQ GUQSH HCIFZ LK8 M2O M7P MBDVC P64 PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM DOA |
| DOI | 10.3390/vaccines9070796 |
| DatabaseName | CrossRef ProQuest Central (Corporate) Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (purchase pre-March 2016) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Engineering Research Database ProQuest Central Student ProQuest Research Library SciTech Premium Collection Biological Sciences Research Library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest Databases ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Research Library Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection Biotechnology and BioEngineering Abstracts ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology Public Health |
| EISSN | 2076-393X |
| ExternalDocumentID | oai_doaj_org_article_625d0b36c9a24e50bc8c783b4d515b39 PMC8310256 10_3390_vaccines9070796 |
| GeographicLocations | Cyprus Portugal Iceland Malta Latvia Austria Netherlands Ireland Luxembourg Poland France Lithuania Bulgaria Croatia Romania Hungary Europe Czech Republic Belgium Norway Finland Denmark Italy Germany Estonia |
| GeographicLocations_xml | – name: Austria – name: Iceland – name: Luxembourg – name: Netherlands – name: Denmark – name: Bulgaria – name: Latvia – name: Germany – name: Lithuania – name: Cyprus – name: Finland – name: Norway – name: Hungary – name: Italy – name: Malta – name: Croatia – name: France – name: Romania – name: Estonia – name: Ireland – name: Czech Republic – name: Poland – name: Portugal – name: Belgium – name: Europe |
| GroupedDBID | 53G 5VS 8FE 8FH 8G5 AADQD AAHBH AAYXX ABUWG ADBBV AEUYN AFFHD AFKRA AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BBNVY BCNDV BENPR BHPHI BPHCQ CCPQU CITATION DIK DWQXO GNUQQ GROUPED_DOAJ GUQSH HCIFZ HYE IAO IHR ITC KQ8 LK8 M2O M48 M7P MODMG M~E OK1 PGMZT PHGZM PHGZT PIMPY PQGLB PQQKQ PROAC RNS RPM 3V. 7T7 7XB 8FD 8FK C1K FR3 MBDVC P64 PKEHL PQEST PQUKI Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c464t-e3765e4b981fee3b2359ba6df246e8cc6a2e4a5265231f058c4f1afe5140464b3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 2 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000677132000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2076-393X |
| IngestDate | Fri Oct 03 12:42:44 EDT 2025 Tue Nov 04 02:00:57 EST 2025 Fri Sep 05 14:50:09 EDT 2025 Fri Jul 25 12:07:00 EDT 2025 Tue Nov 18 21:05:32 EST 2025 Sat Nov 29 07:18:37 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c464t-e3765e4b981fee3b2359ba6df246e8cc6a2e4a5265231f058c4f1afe5140464b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-9997-8417 0000-0003-0756-1639 |
| OpenAccessLink | https://doaj.org/article/625d0b36c9a24e50bc8c783b4d515b39 |
| PMID | 34358212 |
| PQID | 2554654262 |
| PQPubID | 2032320 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_625d0b36c9a24e50bc8c783b4d515b39 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8310256 proquest_miscellaneous_2559425432 proquest_journals_2554654262 crossref_primary_10_3390_vaccines9070796 crossref_citationtrail_10_3390_vaccines9070796 |
| PublicationCentury | 2000 |
| PublicationDate | 20210717 |
| PublicationDateYYYYMMDD | 2021-07-17 |
| PublicationDate_xml | – month: 7 year: 2021 text: 20210717 day: 17 |
| PublicationDecade | 2020 |
| PublicationPlace | Basel |
| PublicationPlace_xml | – name: Basel |
| PublicationTitle | Vaccines (Basel) |
| PublicationYear | 2021 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Strebel (ref_3) 2004; 189 Wolfe (ref_33) 2002; 325 Kavalari (ref_21) 2019; 9 ref_13 ref_11 ref_10 ref_31 Vaz (ref_14) 2020; 14 Patel (ref_6) 2020; 69 Burki (ref_35) 2020; 2 Diana (ref_12) 2019; 15 ref_15 Rao (ref_34) 2011; 53 Hamilton (ref_2) 2020; 47 Deolalikar (ref_30) 2000; 10695 Nathanson (ref_5) 1982; 4 ref_23 Karafillakis (ref_32) 2020; 396 ref_22 Fajfr (ref_18) 2017; 25 Stephens (ref_24) 2007; 369 Kowalzik (ref_16) 2018; 36 ref_20 Loenenbach (ref_25) 2020; 70 ref_29 ref_28 ref_27 ref_9 ref_8 Booy (ref_26) 2019; 15 Bustreo (ref_1) 2015; 100 ref_4 ref_7 Smetana (ref_17) 2018; 3 Pebody (ref_19) 2005; 10 |
| References_xml | – ident: ref_28 – ident: ref_9 – ident: ref_4 doi: 10.1371/journal.pone.0231329 – volume: 15 start-page: 1521 year: 2019 ident: ref_12 article-title: Nouveautés du Plan vaccinal suisse 2019—Sept nouvelles recommandations et implications pratiques pour les praticiens [Update of the 2019 Swiss immunization schedule 7 new recommendations and review of practical implications for health professionals] publication-title: Rev. Med. Suisse – volume: 70 start-page: 2036 year: 2020 ident: ref_25 article-title: The clinical picture and severity of invasive meningococcal disease serogroup w compared with other serogroups in the Netherlands, 2015–2018 publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciz578 – volume: 4 start-page: 940 year: 1982 ident: ref_5 article-title: Eradication of poliomyelitis in the United States publication-title: Rev. Infect. Dis. doi: 10.1093/clinids/4.5.940 – ident: ref_23 doi: 10.3390/antibiotics10070758 – volume: 325 start-page: 430 year: 2002 ident: ref_33 article-title: Anti-vaccinationists past and present publication-title: BMJ doi: 10.1136/bmj.325.7361.430 – ident: ref_7 doi: 10.3390/ijerph18030988 – volume: 25 start-page: 152 year: 2017 ident: ref_18 article-title: Mumps in the eastern bohemia region of the czech republic—A serological survey 2008–2012 publication-title: Cent. Eur. J. Public Health doi: 10.21101/cejph.a4408 – ident: ref_11 – volume: 10695 start-page: 00-32 year: 2000 ident: ref_30 article-title: Socioeconomic determinants of disease transmission in cambodia publication-title: Resour. Future – volume: 10 start-page: 564 year: 2005 ident: ref_19 article-title: Pneumococcal vaccination policy in Europe publication-title: Eurosurveillance doi: 10.2807/esm.10.09.00564-en – ident: ref_27 doi: 10.1186/s12879-020-05462-0 – volume: 2 start-page: e504 year: 2020 ident: ref_35 article-title: The online anti-vaccine movement in the age of COVID-19 publication-title: Lancet Digit. Health doi: 10.1016/S2589-7500(20)30227-2 – ident: ref_22 doi: 10.1016/j.jinf.2021.05.031 – ident: ref_8 – volume: 14 start-page: 20190620 year: 2020 ident: ref_14 article-title: Mandatory Vaccination in Europe publication-title: Pediatrics doi: 10.1542/peds.2019-0620 – volume: 369 start-page: 2196 year: 2007 ident: ref_24 article-title: Epidemic meningitis, meningococcaemia, and Neisseria meningitidis publication-title: Lancet doi: 10.1016/S0140-6736(07)61016-2 – ident: ref_31 – ident: ref_29 – volume: 53 start-page: 95 year: 2011 ident: ref_34 article-title: The MMR vaccine and autism: Sensation, refutation, retraction, and fraud publication-title: Indian J. Psychiatry doi: 10.4103/0019-5545.82529 – volume: 3 start-page: 887 year: 2018 ident: ref_17 article-title: Serological survey of mumps antibodies in adults in the Czech Republic and the need for changes to the vaccination strategy publication-title: Hum. Vaccin. Immunother. doi: 10.1080/21645515.2017.1412021 – volume: 100 start-page: 34 year: 2015 ident: ref_1 article-title: World Health Organization perspectives on the contribution of the Global Alliance for Vaccines and Immunization on reducing child mortality publication-title: Arch. Dis. Child. doi: 10.1136/archdischild-2013-305693 – ident: ref_10 – volume: 36 start-page: 5402 year: 2018 ident: ref_16 article-title: MMR and MMRV vaccines publication-title: Vaccine doi: 10.1016/j.vaccine.2017.07.051 – volume: 9 start-page: 5184 year: 2019 ident: ref_21 article-title: Molecular characterization and epidemiology of Streptococcus pneumoniae serotype 24F in Denmark publication-title: Sci. Rep. doi: 10.1038/s41598-019-41983-8 – volume: 189 start-page: 251 year: 2004 ident: ref_3 article-title: Global measles elimination efforts: The significance of United States measles elimination publication-title: J. Infect. Dis. doi: 10.1086/378092 – ident: ref_15 – volume: 69 start-page: 1700 year: 2020 ident: ref_6 article-title: Progress toward regional measles elimination—Worldwide, 2000–2019 publication-title: MMWR Morb. Mortal. Wkly. Rep. doi: 10.15585/mmwr.mm6945a6 – volume: 396 start-page: 898 year: 2020 ident: ref_32 article-title: Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: A large-scale retrospective temporal modelling study publication-title: Lancet doi: 10.1016/S0140-6736(20)31558-0 – ident: ref_13 – volume: 47 start-page: 467 year: 2020 ident: ref_2 article-title: Recognizing vaccine-preventable diseases and managing outbreaks publication-title: Prim. Care doi: 10.1016/j.pop.2020.05.003 – ident: ref_20 – volume: 15 start-page: 470 year: 2019 ident: ref_26 article-title: Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies publication-title: Hum. Vaccines Immunother. doi: 10.1080/21645515.2018.1532248 |
| SSID | ssj0000913867 |
| Score | 2.1780336 |
| Snippet | Introduction: Despite the widespread availability of vaccines, the incidence of vaccine-preventable childhood diseases (VPCD) started to grow in recent years.... Despite the widespread availability of vaccines, the incidence of vaccine-preventable childhood diseases (VPCD) started to grow in recent years. The aim of the... |
| SourceID | doaj pubmedcentral proquest crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
| StartPage | 796 |
| SubjectTerms | Availability Chicken pox Children Childrens health Coronaviruses COVID-19 vaccines Epidemics Epidemiology Free trade Immunization incidence rate Infectious diseases Measles Morbidity Mumps Poliomyelitis Population Public health Rotavirus Rubella Schedules Standardization Streptococcus infections Trade associations vaccine schedules vaccine-preventable childhood diseases Vaccines Viruses |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1Nb9QwEIZHsOWAhPgoIBYKMhKqODR0EzsfPiEKXXFAqxUqVW-R7YxhJZSUzbZSL_x2ZhLvbgOCC9fYURx5PH49tp8BeEV6zcRVUkQWcx2RItaRkbGKsKjixDnv8y5n5OmnfDYrzs70PATc2nCscu0TO0ddNY5j5IcJH6dKmZ_-9vxHxFmjeHc1pNC4CTtMKlMj2Dk6ns0_b6IsTL0ssrxn-kha3x9eGsc71q3u2HDZYDrqqP0DqTk8KHlt5pne-98234e7QXOKd72RPIAbWO_C_ryHVl8diJPtHaz2QOyL-RZnfbULd_rInugvLD2En-RS-kykovHitP_RKKCg-CKW2OCSxYd--6cVi1qQ0hTr2L8gqdvUwtTVHyXTJaKgGbRCcc10BN-d59xf7SP4Mj0-ef8xClkcIqcytYqQXFiKyuoi9ojSJjLV1mSVT1SGhXOZSVAZpvST1PSTtHDKx8ZjyuCfTFn5GEZ1U-MTEJLEBEk-Y2VFq0ZSL1b5PE8tZlonXuIY3qw7s3QBcc6ZNr6XtNTh3i9_6_0xvN68cN7TPf5e9YitY1ONsdzdg2b5tQyjvKTFZDWxMnPaJArTiXWFywtpVUWy0Uo9hr21oZTBV7Tl1krG8HJTTKOct25Mjc1FV0cr5hZQnXxgk4MGDUvqxbeOF8655EjZPv33x5_B7YTP63TQ0D0YrZYX-BxuucvVol2-CAPrF0gUMi4 priority: 102 providerName: ProQuest |
| Title | Incidence of Vaccine-Preventable Childhood Diseases in the European Union and in the European Free Trade Association Countries |
| URI | https://www.proquest.com/docview/2554654262 https://www.proquest.com/docview/2559425432 https://pubmed.ncbi.nlm.nih.gov/PMC8310256 https://doaj.org/article/625d0b36c9a24e50bc8c783b4d515b39 |
| Volume | 9 |
| WOSCitedRecordID | wos000677132000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2076-393X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000913867 issn: 2076-393X databaseCode: DOA dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2076-393X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000913867 issn: 2076-393X databaseCode: M~E dateStart: 20130101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2076-393X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000913867 issn: 2076-393X databaseCode: M7P dateStart: 20130301 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2076-393X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000913867 issn: 2076-393X databaseCode: BENPR dateStart: 20130301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2076-393X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000913867 issn: 2076-393X databaseCode: PIMPY dateStart: 20130301 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 2076-393X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000913867 issn: 2076-393X databaseCode: M2O dateStart: 20130301 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ3Pb9MwFMctGBy4IMYPUdgqI6GJw8Ia24ntI9tagcRKhMZUTpHtPGuVUIqabtIu-9t5dtKuASEuXHyIHcmxn_2-ju3PI-Qt6jWTVkwlFqROUBHrxPBUJKCqlDnnvYwxIy8-y-lUzWa62Ar1Fc6EtXjgtuGOUJ9XI8tzpw0TkI2sU04qbkWFntjyeHUPVc_WYirOwTrlKpcty4fjuv7o2riwU93oyITLe24o0vp7ErN_QHLL40yekMedVKQf2irukntQPyUHRcuavjmk53dXp5pDekCLOwr1zTNyiyO_DRhKF55etPVKOmJTuC9FN1Rjetru0jR0XlMUhHT9i56iIl3U1NTVHzmTJQBFR1cB3ephGq64hxBdzXPybTI-P_mYdMEWEidysUoAZ5oMhNUq9QDcMp5pa_LKM5GDci43DIQJMH1UhH6UKSd8ajxkgc-TC8tfkJ16UcNLQjn6fFRmxvIKF3coMqzwUmYWcq2Z5zAg79dtX7qORB4CYvwocUUSOqv8rbMG5N3mhZ8thOPvRY9DZ26KBXp2fIA2VXY2Vf7LpgZkb20KZTekm5KF83xZAPgPyJtNNg7GsMNialhcxTJaBLwAlpE9E-pVqJ9Tzy8j1juEfEMB-up_fMFr8oiFwzeRALpHdlbLK9gnD931at4sh-S-nKkheXA8nhZfh3HkYHrGvoRUFiG9HWN-8ems-P4L4DMkzQ |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgkQlxKOAWChgJKg4NHTXdh4-IASUVasuqz0sVW_BdpyyEkrKZlu0F34Sv5GZvLYBwa0HrrHzkDMz_uwZfx_Ac8RrepDwyDMuVB4iYuVpMZCei5IBtzZNw1Iz8mgUjsfR8bGarMHP5iwMlVU2MbEM1EluaY98l1M5lU_86W9Ov3mkGkXZ1UZCozKLQ7f8jku24vXBHv7fF5wPP0zf73u1qoBnZSAXnkOX8p00KhqkzgnDha-MDpKUy8BF1gaaO6mJNR6hT9r3IyvTgU6dT0Q0gTQCn3sFriKM4FFZKjhp93SIYzMKwopBSAjV3z3XlvLjhSqZ6ILO5FdqBHSAbbcs88I8N7z1v43QbbhZI2r2tnKBO7Dmsk3YnlSU3MsdNl2dMCt22DabrMi6l5two9q3ZNVxrLvwAwNmpbPK8pQdVQPr1URXdMyMtWTQbK9KbhVsljHE0azJbDAE8nnGdJb80TKcO8cQHySOXXAMRswApGxW3INPlzJW92E9yzP3AJhAqISAVhuR4JoYsZmRaRj6xgVK8VS4HrxqjCe2NYE76Yh8jXEhR9YW_2ZtPXjZ3nBacZf8ves7ssa2G5GOlxfy-Ulcx7AYl8pJ34jAKs2l8_vGRjaMhJEJgmIjVA-2GsOM60hYxCur7MGzthljGCWmdObys7KPksTKgH3Cjg90Pqjbks2-lGzopJSHuP3hv1_-FK7vTz-O4tHB-PARbHCqTCrpUbdgfTE_c4_hmj1fzIr5k9KlGXy-bA_5BZrDjX8 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VFiEkxKOAWChgJKg4NOzGdh4-IETZrqharSJUqt6C7diwEkrKZlu0F34Yv45xXtuA4NYD19h5yJkZf_aMvw_gOeI16Wc09pSJhIeIWHiS-dwzceZTra2NKs3I48NoOo1PTkSyBj_bszCurLKNiVWgzgrt9siH1JVTBY4_fWibsohkPHlz-s1zClIu09rKadQmcmCW33H5Vr7eH-O_fkHpZO_o3XuvURjwNA_5wjPoXoHhSsS-NYYpygKhZJhZykMTax1Karh0DPIIg-woiDW3vrQmcKQ0IVcMn3sFNiIEGehdG7t70-RDt8PjGDfjMKr5hBgTo-G51C5bXoqKly7sTYWVYkAP5vaLNC_MepNb__N43YabDdYmb2vnuANrJt-E7aQm617ukKPV2bNyh2yTZEXjvdyEG_WOJqkPat2FHxhKawVWUlhyXA-y11BguQNopKOJJuM67VWSWU4QYZM250EQ4hc5kXn2R8tkbgxB5JAZcsFliOMMcJpn5T34eCljdR_W8yI3D4AwBFEIdaViGa6WEbUpbqMoUCYUglpmBvCqNaRUN9TuTmHka4pLPGd56W-WN4CX3Q2nNavJ37vuOsvsujk68upCMf-cNtEtxUV0NlIs1EJSboKR0rGOYqZ4hnBZMTGArdZI0yZGlunKQgfwrGvG6OZSVjI3xVnVR3DH14B9op4_9D6o35LPvlQ86U5DDxH9w3-__ClcQ8dID_enB4_gOnUlSxVv6hasL-Zn5jFc1eeLWTl_0vg3gU-X7SK_ANrbl48 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Incidence+of+Vaccine-Preventable+Childhood+Diseases+in+the+European+Union+and+in+the+European+Free+Trade+Association+Countries&rft.jtitle=Vaccines+%28Basel%29&rft.au=Jachowicz%2C+Estera&rft.au=G%C4%99bicka%2C+Magdalena&rft.au=Plakhtyr%2C+Daria&rft.au=Shynkarenko%2C+Myroslav&rft.date=2021-07-17&rft.issn=2076-393X&rft.eissn=2076-393X&rft.volume=9&rft.issue=7&rft.spage=796&rft_id=info:doi/10.3390%2Fvaccines9070796&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_vaccines9070796 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2076-393X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2076-393X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2076-393X&client=summon |